Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients (Q35788831)

10 August 2017

Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients (English)

1 reference

10 August 2017

3

Yukihiko Sonoda

1 reference

10 August 2017

8

Tatsuhiro Shibata

1 reference

10 August 2017

Masayuki Kanamori

1

1 reference

10 August 2017

Tsuyoshi Higa

2

1 reference

10 August 2017

Shohei Murakami

4

1 reference

10 August 2017

Mina Dodo

5

1 reference

10 August 2017

Hiroshi Kitamura

6

1 reference

10 August 2017

Keiko Taguchi

7

1 reference

10 August 2017

Mika Watanabe

9

1 reference

10 August 2017

Hiroyoshi Suzuki

10

1 reference

10 August 2017

Ichiyo Shibahara

11

1 reference

10 August 2017

Ryuta Saito

12

1 reference

10 August 2017

Yoji Yamashita

13

1 reference

10 August 2017

Toshihiro Kumabe

14

1 reference

10 August 2017

Masayuki Yamamoto

15

1 reference

10 August 2017

Hozumi Motohashi

16

1 reference

10 August 2017

Teiji Tominaga

17

1 reference

10 August 2017

10 October 2014

1 reference

10 August 2017

1 reference

10 August 2017

17

1 reference

10 August 2017

4

1 reference

10 August 2017

555-565

1 reference

describes a project that uses

10 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4483074/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

NRF2 immunolocalization in human breast cancer patients as a prognostic factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Analysis of the IDH1 codon 132 mutation in brain tumors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

An integrated genomic analysis of human glioblastoma multiforme

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Nrf2-Keap1 defines a physiologically important stress response mechanism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483074

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

12 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Somatic mutations of the KEAP1 gene in common solid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU282

Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25304134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25304134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NEUONC/NOU282

1 reference

10 August 2017

1 reference

10 August 2017

1 reference